133 related articles for article (PubMed ID: 38881902)
41. Glycosylation Modulates Plasma Membrane Trafficking of CD24 in Breast Cancer Cells.
Chantziou A; Theodorakis K; Polioudaki H; de Bree E; Kampa M; Mavroudis D; Castanas E; Theodoropoulos PA
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360932
[TBL] [Abstract][Full Text] [Related]
42. SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.
Hüser L; Sachindra S; Granados K; Federico A; Larribère L; Novak D; Umansky V; Altevogt P; Utikal J
Int J Cancer; 2018 Dec; 143(12):3131-3142. PubMed ID: 29905375
[TBL] [Abstract][Full Text] [Related]
43. CD24, A Review of its Role in Tumor Diagnosis, Progression and Therapy.
Ni YH; Zhao X; Wang W
Curr Gene Ther; 2020; 20(2):109-126. PubMed ID: 32576128
[TBL] [Abstract][Full Text] [Related]
44. Heparanase promotes glioma progression via enhancing CD24 expression.
Barash U; Spyrou A; Liu P; Vlodavsky E; Zhu C; Luo J; Su D; Ilan N; Forsberg-Nilsson K; Vlodavsky I; Yang X
Int J Cancer; 2019 Sep; 145(6):1596-1608. PubMed ID: 31032901
[TBL] [Abstract][Full Text] [Related]
45. Knockdown of CD24 inhibits proliferation, invasion and sensitizes breast cancer MCF-7 cells to tamoxifen in vitro.
Ma ZL; Chen YP; Song JL; Wang YQ
Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2394-9. PubMed ID: 26214774
[TBL] [Abstract][Full Text] [Related]
46. Targeted Intervention of NF2-YAP Signaling Axis in CD24-Overexpressing Cells Contributes to Encouraging Therapeutic Effects in TNBC.
Hou L; Pu L; Chen Y; Bai Y; Zhou Y; Chen M; Wang S; Lv Y; Ma C; Cheng P; Zhang K; Liang Q; Deng S; Wang D
ACS Nano; 2022 Apr; 16(4):5807-5819. PubMed ID: 35420780
[TBL] [Abstract][Full Text] [Related]
47. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma.
Han J; Fujisawa T; Husain SR; Puri RK
BMC Cancer; 2014 Mar; 14():173. PubMed ID: 24612587
[TBL] [Abstract][Full Text] [Related]
48. CD24-targeted fluorescence imaging in patient-derived xenograft models of high-grade serous ovarian carcinoma.
Kleinmanns K; Bischof K; Anandan S; Popa M; Akslen LA; Fosse V; Karlsen IT; Gjertsen BT; Bjørge L; McCormack E
EBioMedicine; 2020 Jun; 56():102782. PubMed ID: 32454401
[TBL] [Abstract][Full Text] [Related]
49. Surprising magic of CD24 beyond cancer.
Wang H; Shi P; Shi X; Lv Y; Xie H; Zhao H
Front Immunol; 2023; 14():1334922. PubMed ID: 38313430
[TBL] [Abstract][Full Text] [Related]
50. Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec-10 Signaling Pathway.
Wang K; Yu A; Liu K; Feng C; Hou Y; Chen J; Ma S; Huang L; Dai X
Adv Sci (Weinh); 2023 May; 10(13):e2300288. PubMed ID: 36866919
[TBL] [Abstract][Full Text] [Related]
51. The biological roles of CD24 in ovarian cancer: old story, but new tales.
Gu Y; Zhou G; Tang X; Shen F; Ding J; Hua K
Front Immunol; 2023; 14():1183285. PubMed ID: 37359556
[TBL] [Abstract][Full Text] [Related]
52. CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation.
Ahmed MA; Jackson D; Seth R; Robins A; Lobo DN; Tomlinson IP; Ilyas M
Inflamm Bowel Dis; 2010 May; 16(5):795-803. PubMed ID: 19998456
[TBL] [Abstract][Full Text] [Related]
53. Association of human breast cancer CD44
Qiao X; Zhang Y; Sun L; Ma Q; Yang J; Ai L; Xue J; Chen G; Zhang H; Ji C; Gu X; Lei H; Yang Y; Liu C
Elife; 2021 Jul; 10():. PubMed ID: 34318746
[TBL] [Abstract][Full Text] [Related]
54. Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple-Negative Breast Cancer.
Chan SH; Tsai KW; Chiu SY; Kuo WH; Chen HY; Jiang SS; Chang KJ; Hung WC; Wang LH
Mol Cancer Ther; 2019 Jan; 18(1):147-161. PubMed ID: 30381446
[TBL] [Abstract][Full Text] [Related]
55. Attenuated Listeria monocytogenes as a cancer vaccine vector for the delivery of CD24, a biomarker for hepatic cancer stem cells.
Yang Y; Hou J; Lin Z; Zhuo H; Chen D; Zhang X; Chen Y; Sun B
Cell Mol Immunol; 2014 Mar; 11(2):184-96. PubMed ID: 24488178
[TBL] [Abstract][Full Text] [Related]
56. CD24 cross-linking induces apoptosis in, and inhibits migration of, MCF-7 breast cancer cells.
Kim JB; Ko E; Han W; Lee JE; Lee KM; Shin I; Kim S; Lee JW; Cho J; Bae JY; Jee HG; Noh DY
BMC Cancer; 2008 Apr; 8():118. PubMed ID: 18433506
[TBL] [Abstract][Full Text] [Related]
57. Overview of CD24 as a new molecular marker in ovarian cancer.
Tarhriz V; Bandehpour M; Dastmalchi S; Ouladsahebmadarek E; Zarredar H; Eyvazi S
J Cell Physiol; 2019 Mar; 234(3):2134-2142. PubMed ID: 30317611
[TBL] [Abstract][Full Text] [Related]
58. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
[TBL] [Abstract][Full Text] [Related]
59. CD24 promotes invasion of glioma cells in vivo.
Senner V; Sturm A; Baur I; Schrell UH; Distel L; Paulus W
J Neuropathol Exp Neurol; 1999 Aug; 58(8):795-802. PubMed ID: 10446804
[TBL] [Abstract][Full Text] [Related]
60. CD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34a.
Muppala S; Mudduluru G; Leupold JH; Buergy D; Sleeman JP; Allgayer H
PLoS One; 2013; 8(3):e59563. PubMed ID: 23533633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
